Colonial River Investments LLC Purchases 118 Shares of The Allstate Co. (NYSE:ALL)

Colonial River Investments LLC lifted its position in shares of The Allstate Co. (NYSE:ALLFree Report) by 4.9% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 2,535 shares of the insurance provider’s stock after acquiring an additional 118 shares during the quarter. Colonial River Investments LLC’s holdings in Allstate were worth $489,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Strategic Financial Concepts LLC boosted its stake in Allstate by 15,062.3% in the 4th quarter. Strategic Financial Concepts LLC now owns 1,119,129 shares of the insurance provider’s stock worth $215,757,000 after purchasing an additional 1,111,748 shares during the period. TimesSquare Capital Management LLC bought a new position in Allstate in the 3rd quarter worth about $77,819,000. Los Angeles Capital Management LLC boosted its stake in Allstate by 688.4% in the 3rd quarter. Los Angeles Capital Management LLC now owns 460,282 shares of the insurance provider’s stock worth $87,292,000 after purchasing an additional 401,901 shares during the period. Caisse DE Depot ET Placement DU Quebec boosted its stake in Allstate by 291.9% in the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 356,065 shares of the insurance provider’s stock worth $67,528,000 after purchasing an additional 265,213 shares during the period. Finally, Prana Capital Management LP boosted its stake in Allstate by 539.9% in the 3rd quarter. Prana Capital Management LP now owns 273,655 shares of the insurance provider’s stock worth $51,899,000 after purchasing an additional 230,893 shares during the period. Institutional investors own 76.47% of the company’s stock.

Allstate Price Performance

Shares of ALL stock opened at $185.51 on Monday. The firm has a market cap of $49.12 billion, a P/E ratio of 10.92, a P/E/G ratio of 1.03 and a beta of 0.52. The Allstate Co. has a fifty-two week low of $153.87 and a fifty-two week high of $209.88. The business’s 50 day moving average price is $190.25 and its 200-day moving average price is $190.43. The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.40 and a current ratio of 0.36.

Allstate (NYSE:ALLGet Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share for the quarter, topping analysts’ consensus estimates of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. On average, equities research analysts anticipate that The Allstate Co. will post 18.65 earnings per share for the current year.

Insider Transactions at Allstate

In other news, CFO Jesse E. Merten sold 40,102 shares of Allstate stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the sale, the chief financial officer now directly owns 18,115 shares in the company, valued at approximately $3,378,990.95. This trade represents a 68.88 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.80% of the company’s stock.

Analysts Set New Price Targets

ALL has been the subject of several analyst reports. UBS Group raised their target price on Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. Evercore ISI upgraded Allstate from an “in-line” rating to an “outperform” rating in a research note on Wednesday, January 8th. Wells Fargo & Company raised their target price on Allstate from $186.00 to $187.00 and gave the stock an “equal weight” rating in a research note on Tuesday, January 14th. Jefferies Financial Group raised their price target on Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a report on Friday, November 8th. Finally, Morgan Stanley raised their price objective on Allstate from $220.00 to $228.00 and gave the company an “overweight” rating in a report on Thursday, November 7th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $217.94.

View Our Latest Analysis on ALL

About Allstate

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Articles

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALLFree Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.